Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 2.000
+0.200 (11.11%)
May 8, 2026, 3:40 PM GMT
Renalytix Earnings Call Transcripts
Fiscal Year 2025
-
Revenue is on track for $3.2M in FY2025 with 20% quarterly growth, driven by Medicare coverage and direct-to-doctor sales. Operational improvements have reduced costs and turnaround times, while strategic pharma collaborations and a strong US focus support future expansion.